Middlemore Clinical Trials ( Site 1000)

Auckland 2025

0 studies enrolling now · 1 studies all time

What they study most

Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis

Studies at this site

• A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001) — Completed